Coronary Artery Disease
Stent fracture—Unusual cause of DES restenosis
B.K. Goyal MD, FRCP, FACC, FSCAI,
Corresponding Author
B.K. Goyal MD, FRCP, FACC, FSCAI
Director Interventional Cardiology, Bombay Hospital, Mumbai
Dean's Office, Bombay Hospital, 12, New Marine Lines, Mumbai-400020, India
Search for more papers by this author
B.K. Goyal MD, FRCP, FACC, FSCAI,
Corresponding Author
B.K. Goyal MD, FRCP, FACC, FSCAI
Director Interventional Cardiology, Bombay Hospital, Mumbai
Dean's Office, Bombay Hospital, 12, New Marine Lines, Mumbai-400020, India
Search for more papers by this author
First published: 24 May 2007
No abstract is available for this article.
REFERENCES
- 1
Duda SH,
Pusich B,
Richter G, et al.
Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: Six-month results.
Circulation
2002;
106:
1505–1509.
- 2
Scheinert D,
Scheinert S,
Sax J,
Piorkowski C,
Braunlich S,
Ulrich M, et al.
Prevalence and clinical impact of stent fractures after femoropopliteal stenting.
J Am Coll Cardiol
2005;
45:
312–315.
- 3
Takebayashi H,
Mintz GS,
Carlier SG,
Kobayashi Y,
Fujii K,
Yasuda T,
Costa RA,
Moussa I,
Dangas GD,
Mehran R,
Lansky AJ,
Kreps E,
Collins MB,
Colombo A,
Stone GW,
Leon MB,
Moses JW.
Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation.
Circulation
2004;
110:
3430–3434.
- 4
Lemos PA,
Saia F,
Ligthart JM, et al.
Coronary restenosis after sirolimus-eluting stent implantationmorphological description and mechanistic analysis from a consecutive series of cases.
Circulation
2003;
108:
257–260.
